MARKET

VIR

VIR

Vir Biotechnology, Inc.
NASDAQ
4.700
-0.600
-11.32%
After Hours: 4.800 +0.1 +2.13% 19:46 05/13 EDT
OPEN
5.32
PREV CLOSE
5.30
HIGH
5.39
LOW
4.690
VOLUME
2.56M
TURNOVER
--
52 WEEK HIGH
14.45
52 WEEK LOW
4.690
MARKET CAP
649.72M
P/E (TTM)
-1.1127
1D
5D
1M
3M
1Y
5Y
1D
Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference
Barchart · 1d ago
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga · 1d ago
Vir Biotechnology Is Maintained at Buy by Needham
Dow Jones · 1d ago
Vir Biotechnology Price Target Cut to $14.00/Share From $19.00 by Needham
Dow Jones · 1d ago
Needham Maintains Buy on Vir Biotechnology, Lowers Price Target to $14
Benzinga · 1d ago
Vir Biotechnology (VIR) Receives a Buy from Needham
TipRanks · 1d ago
Analysts’ Top Healthcare Picks: Tenaya Therapeutics (TNYA), Green Thumb Industries (GTBIF)
TipRanks · 1d ago
VIR BIOTECHNOLOGY INC <VIR.O>: LEERINK PARTNERS CUTS TARGET PRICE TO $16 FROM $20
Reuters · 1d ago
More
About VIR
More
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. It also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Tobevibart is an investigational neutralizing monoclonal antibody (mAb) that has been engineered for immune engagement and targets a conserved region on the hepatitis B surface antigen (HBsAg). Elebsiran is an investigational HBV-targeted small interfering RNA (siRNA) that reduces HBsAg. Its pipeline includes VIR-5818, VIR-5500, VIR-5525, and HIV Cure. It also has rights to the PRO-XTEN masking platform for oncology and infectious disease.
Recently
Symbol
Price
%Change
    VIR
  • 4.700
  • -11.32%

Webull offers Vir Biotechnology Inc stock information, including NASDAQ: VIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VIR stock methods without spending real money on the virtual paper trading platform.